Trial Profile

A phase 1 study of 710GO

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 30 Mar 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs 710 GO (Primary)
Indications Obesity; Overweight
Focus Adverse reactions; First in man

Most Recent Events

19 Mar 2026 According to an Endevica Bio media release, company expects to initiate a first-in-human, randomized, placebo-controlled Phase 1 clinical trial of 710GO in healthy overweight and obese volunteers in the first half of 2026.
07 Nov 2024 New trial record
01 Nov 2024 According to an Endevica Bio media release, company hopes to conduct a phase 1 trial on the drug starting in the second half of 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com